Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Cystic Fibrosis Therapeutics Market Growth (Status and Outlook) 2022-2028

  • LP 4902263
  • 110 Pages
  • March 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Cystic Fibrosis Therapeutics will have significant change from previous year. According to our (LP Information) latest study, the global Cystic Fibrosis Therapeutics market size is USD million in 2022 from USD 4950.4 million in 2021, with a change of % between 2021 and 2022. The global Cystic Fibrosis Therapeutics market size will reach USD 12390 million in 2028, growing at a CAGR of 14.0% over the analysis period.

The United States Cystic Fibrosis Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cystic Fibrosis Therapeutics market, reaching US$ million by the year 2028. As for the Europe Cystic Fibrosis Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Cystic Fibrosis Therapeutics players cover Vertex Pharmaceuticals, F. Hoffmann-La Roche, AbbVie, and Gilead Sciences, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Cystic Fibrosis Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

CFTR

Mucolytics

PERT

Anti-infectives

Bronchodilators

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Hospitals

Clinics

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Vertex Pharmaceuticals

F. Hoffmann-La Roche

AbbVie

Gilead Sciences

Novartis

AstraZeneca

Bayer

Celtaxsys

Pharmaxis

ProQR Therapeutics

PTC Therapeutics

Alcresta Therapeutics

Insmed Incorporated

Savara

Cyclacel Pharmaceuticals

Vectura

Allergan

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Cystic Fibrosis Therapeutics Market Size 2017-2028

2.1.2 Cystic Fibrosis Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Cystic Fibrosis Therapeutics Segment by Type

2.2.1 CFTR

2.2.2 Mucolytics

2.2.3 PERT

2.2.4 Anti-infectives

2.2.5 Bronchodilators

2.3 Cystic Fibrosis Therapeutics Market Size by Type

2.3.1 Cystic Fibrosis Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Cystic Fibrosis Therapeutics Market Size Market Share by Type (2017-2022)

2.4 Cystic Fibrosis Therapeutics Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.5 Cystic Fibrosis Therapeutics Market Size by Application

2.5.1 Cystic Fibrosis Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Cystic Fibrosis Therapeutics Market Size Market Share by Application (2017-2022)

3 Cystic Fibrosis Therapeutics Market Size by Player

3.1 Cystic Fibrosis Therapeutics Market Size Market Share by Players

3.1.1 Global Cystic Fibrosis Therapeutics Revenue by Players (2020-2022)

3.1.2 Global Cystic Fibrosis Therapeutics Revenue Market Share by Players (2020-2022)

3.2 Global Cystic Fibrosis Therapeutics Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Cystic Fibrosis Therapeutics by Regions

4.1 Cystic Fibrosis Therapeutics Market Size by Regions (2017-2022)

4.2 Americas Cystic Fibrosis Therapeutics Market Size Growth (2017-2022)

4.3 APAC Cystic Fibrosis Therapeutics Market Size Growth (2017-2022)

4.4 Europe Cystic Fibrosis Therapeutics Market Size Growth (2017-2022)

4.5 Middle East & Africa Cystic Fibrosis Therapeutics Market Size Growth (2017-2022)

5 Americas

5.1 Americas Cystic Fibrosis Therapeutics Market Size by Country (2017-2022)

5.2 Americas Cystic Fibrosis Therapeutics Market Size by Type (2017-2022)

5.3 Americas Cystic Fibrosis Therapeutics Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Cystic Fibrosis Therapeutics Market Size by Region (2017-2022)

6.2 APAC Cystic Fibrosis Therapeutics Market Size by Type (2017-2022)

6.3 APAC Cystic Fibrosis Therapeutics Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Cystic Fibrosis Therapeutics by Country (2017-2022)

7.2 Europe Cystic Fibrosis Therapeutics Market Size by Type (2017-2022)

7.3 Europe Cystic Fibrosis Therapeutics Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Cystic Fibrosis Therapeutics by Region (2017-2022)

8.2 Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Type (2017-2022)

8.3 Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Cystic Fibrosis Therapeutics Market Forecast

10.1 Global Cystic Fibrosis Therapeutics Forecast by Regions (2023-2028)

10.1.1 Global Cystic Fibrosis Therapeutics Forecast by Regions (2023-2028)

10.1.2 Americas Cystic Fibrosis Therapeutics Forecast

10.1.3 APAC Cystic Fibrosis Therapeutics Forecast

10.1.4 Europe Cystic Fibrosis Therapeutics Forecast

10.1.5 Middle East & Africa Cystic Fibrosis Therapeutics Forecast

10.2 Americas Cystic Fibrosis Therapeutics Forecast by Country (2023-2028)

10.2.1 United States Cystic Fibrosis Therapeutics Market Forecast

10.2.2 Canada Cystic Fibrosis Therapeutics Market Forecast

10.2.3 Mexico Cystic Fibrosis Therapeutics Market Forecast

10.2.4 Brazil Cystic Fibrosis Therapeutics Market Forecast

10.3 APAC Cystic Fibrosis Therapeutics Forecast by Region (2023-2028)

10.3.1 China Cystic Fibrosis Therapeutics Market Forecast

10.3.2 Japan Cystic Fibrosis Therapeutics Market Forecast

10.3.3 Korea Cystic Fibrosis Therapeutics Market Forecast

10.3.4 Southeast Asia Cystic Fibrosis Therapeutics Market Forecast

10.3.5 India Cystic Fibrosis Therapeutics Market Forecast

10.3.6 Australia Cystic Fibrosis Therapeutics Market Forecast

10.4 Europe Cystic Fibrosis Therapeutics Forecast by Country (2023-2028)

10.4.1 Germany Cystic Fibrosis Therapeutics Market Forecast

10.4.2 France Cystic Fibrosis Therapeutics Market Forecast

10.4.3 UK Cystic Fibrosis Therapeutics Market Forecast

10.4.4 Italy Cystic Fibrosis Therapeutics Market Forecast

10.4.5 Russia Cystic Fibrosis Therapeutics Market Forecast

10.5 Middle East & Africa Cystic Fibrosis Therapeutics Forecast by Region (2023-2028)

10.5.1 Egypt Cystic Fibrosis Therapeutics Market Forecast

10.5.2 South Africa Cystic Fibrosis Therapeutics Market Forecast

10.5.3 Israel Cystic Fibrosis Therapeutics Market Forecast

10.5.4 Turkey Cystic Fibrosis Therapeutics Market Forecast

10.5.5 GCC Countries Cystic Fibrosis Therapeutics Market Forecast

10.6 Global Cystic Fibrosis Therapeutics Forecast by Type (2023-2028)

10.7 Global Cystic Fibrosis Therapeutics Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Vertex Pharmaceuticals

11.1.1 Vertex Pharmaceuticals Company Information

11.1.2 Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Product Offered

11.1.3 Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Vertex Pharmaceuticals Main Business Overview

11.1.5 Vertex Pharmaceuticals Latest Developments

11.2 F. Hoffmann-La Roche

11.2.1 F. Hoffmann-La Roche Company Information

11.2.2 F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Product Offered

11.2.3 F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 F. Hoffmann-La Roche Main Business Overview

11.2.5 F. Hoffmann-La Roche Latest Developments

11.3 AbbVie

11.3.1 AbbVie Company Information

11.3.2 AbbVie Cystic Fibrosis Therapeutics Product Offered

11.3.3 AbbVie Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 AbbVie Main Business Overview

11.3.5 AbbVie Latest Developments

11.4 Gilead Sciences

11.4.1 Gilead Sciences Company Information

11.4.2 Gilead Sciences Cystic Fibrosis Therapeutics Product Offered

11.4.3 Gilead Sciences Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Gilead Sciences Main Business Overview

11.4.5 Gilead Sciences Latest Developments

11.5 Novartis

11.5.1 Novartis Company Information

11.5.2 Novartis Cystic Fibrosis Therapeutics Product Offered

11.5.3 Novartis Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Novartis Main Business Overview

11.5.5 Novartis Latest Developments

11.6 AstraZeneca

11.6.1 AstraZeneca Company Information

11.6.2 AstraZeneca Cystic Fibrosis Therapeutics Product Offered

11.6.3 AstraZeneca Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 AstraZeneca Main Business Overview

11.6.5 AstraZeneca Latest Developments

11.7 Bayer

11.7.1 Bayer Company Information

11.7.2 Bayer Cystic Fibrosis Therapeutics Product Offered

11.7.3 Bayer Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Bayer Main Business Overview

11.7.5 Bayer Latest Developments

11.8 Celtaxsys

11.8.1 Celtaxsys Company Information

11.8.2 Celtaxsys Cystic Fibrosis Therapeutics Product Offered

11.8.3 Celtaxsys Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Celtaxsys Main Business Overview

11.8.5 Celtaxsys Latest Developments

11.9 Pharmaxis

11.9.1 Pharmaxis Company Information

11.9.2 Pharmaxis Cystic Fibrosis Therapeutics Product Offered

11.9.3 Pharmaxis Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Pharmaxis Main Business Overview

11.9.5 Pharmaxis Latest Developments

11.10 ProQR Therapeutics

11.10.1 ProQR Therapeutics Company Information

11.10.2 ProQR Therapeutics Cystic Fibrosis Therapeutics Product Offered

11.10.3 ProQR Therapeutics Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 ProQR Therapeutics Main Business Overview

11.10.5 ProQR Therapeutics Latest Developments

11.11 PTC Therapeutics

11.11.1 PTC Therapeutics Company Information

11.11.2 PTC Therapeutics Cystic Fibrosis Therapeutics Product Offered

11.11.3 PTC Therapeutics Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 PTC Therapeutics Main Business Overview

11.11.5 PTC Therapeutics Latest Developments

11.12 Alcresta Therapeutics

11.12.1 Alcresta Therapeutics Company Information

11.12.2 Alcresta Therapeutics Cystic Fibrosis Therapeutics Product Offered

11.12.3 Alcresta Therapeutics Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Alcresta Therapeutics Main Business Overview

11.12.5 Alcresta Therapeutics Latest Developments

11.13 Insmed Incorporated

11.13.1 Insmed Incorporated Company Information

11.13.2 Insmed Incorporated Cystic Fibrosis Therapeutics Product Offered

11.13.3 Insmed Incorporated Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Insmed Incorporated Main Business Overview

11.13.5 Insmed Incorporated Latest Developments

11.14 Savara

11.14.1 Savara Company Information

11.14.2 Savara Cystic Fibrosis Therapeutics Product Offered

11.14.3 Savara Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Savara Main Business Overview

11.14.5 Savara Latest Developments

11.15 Cyclacel Pharmaceuticals

11.15.1 Cyclacel Pharmaceuticals Company Information

11.15.2 Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Product Offered

11.15.3 Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Cyclacel Pharmaceuticals Main Business Overview

11.15.5 Cyclacel Pharmaceuticals Latest Developments

11.16 Vectura

11.16.1 Vectura Company Information

11.16.2 Vectura Cystic Fibrosis Therapeutics Product Offered

11.16.3 Vectura Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Vectura Main Business Overview

11.16.5 Vectura Latest Developments

11.17 Allergan

11.17.1 Allergan Company Information

11.17.2 Allergan Cystic Fibrosis Therapeutics Product Offered

11.17.3 Allergan Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Allergan Main Business Overview

11.17.5 Allergan Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Cystic Fibrosis Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of CFTR

Table 3. Major Players of Mucolytics

Table 4. Major Players of PERT

Table 5. Major Players of Anti-infectives

Table 6. Major Players of Bronchodilators

Table 7. Cystic Fibrosis Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Cystic Fibrosis Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 9. Global Cystic Fibrosis Therapeutics Market Size Market Share by Type (2017-2022)

Table 10. Cystic Fibrosis Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Cystic Fibrosis Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 12. Global Cystic Fibrosis Therapeutics Market Size Market Share by Application (2017-2022)

Table 13. Global Cystic Fibrosis Therapeutics Revenue by Players (2020-2022) & ($ Millions)

Table 14. Global Cystic Fibrosis Therapeutics Revenue Market Share by Player (2020-2022)

Table 15. Cystic Fibrosis Therapeutics Key Players Head office and Products Offered

Table 16. Cystic Fibrosis Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 17. New Products and Potential Entrants

Table 18. Mergers & Acquisitions, Expansion

Table 19. Global Cystic Fibrosis Therapeutics Market Size by Regions 2017-2022 & ($ Millions)

Table 20. Global Cystic Fibrosis Therapeutics Market Size Market Share by Regions (2017-2022)

Table 21. Americas Cystic Fibrosis Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 22. Americas Cystic Fibrosis Therapeutics Market Size Market Share by Country (2017-2022)

Table 23. Americas Cystic Fibrosis Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 24. Americas Cystic Fibrosis Therapeutics Market Size Market Share by Type (2017-2022)

Table 25. Americas Cystic Fibrosis Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 26. Americas Cystic Fibrosis Therapeutics Market Size Market Share by Application (2017-2022)

Table 27. APAC Cystic Fibrosis Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 28. APAC Cystic Fibrosis Therapeutics Market Size Market Share by Region (2017-2022)

Table 29. APAC Cystic Fibrosis Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 30. APAC Cystic Fibrosis Therapeutics Market Size Market Share by Type (2017-2022)

Table 31. APAC Cystic Fibrosis Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 32. APAC Cystic Fibrosis Therapeutics Market Size Market Share by Application (2017-2022)

Table 33. Europe Cystic Fibrosis Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 34. Europe Cystic Fibrosis Therapeutics Market Size Market Share by Country (2017-2022)

Table 35. Europe Cystic Fibrosis Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 36. Europe Cystic Fibrosis Therapeutics Market Size Market Share by Type (2017-2022)

Table 37. Europe Cystic Fibrosis Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 38. Europe Cystic Fibrosis Therapeutics Market Size Market Share by Application (2017-2022)

Table 39. Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Cystic Fibrosis Therapeutics Market Size Market Share by Region (2017-2022)

Table 41. Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Cystic Fibrosis Therapeutics Market Size Market Share by Type (2017-2022)

Table 43. Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Cystic Fibrosis Therapeutics Market Size Market Share by Application (2017-2022)

Table 45. Key Market Drivers & Growth Opportunities of Cystic Fibrosis Therapeutics

Table 46. Key Market Challenges & Risks of Cystic Fibrosis Therapeutics

Table 47. Key Industry Trends of Cystic Fibrosis Therapeutics

Table 48. Global Cystic Fibrosis Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 49. Global Cystic Fibrosis Therapeutics Market Size Market Share Forecast by Regions (2023-2028)

Table 50. Global Cystic Fibrosis Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 51. Global Cystic Fibrosis Therapeutics Market Size Market Share Forecast by Type (2023-2028)

Table 52. Global Cystic Fibrosis Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 53. Global Cystic Fibrosis Therapeutics Market Size Market Share Forecast by Application (2023-2028)

Table 54. Vertex Pharmaceuticals Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors

Table 55. Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Product Offered

Table 56. Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 57. Vertex Pharmaceuticals Main Business

Table 58. Vertex Pharmaceuticals Latest Developments

Table 59. F. Hoffmann-La Roche Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors

Table 60. F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Product Offered

Table 61. F. Hoffmann-La Roche Main Business

Table 62. F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 63. F. Hoffmann-La Roche Latest Developments

Table 64. AbbVie Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors

Table 65. AbbVie Cystic Fibrosis Therapeutics Product Offered

Table 66. AbbVie Main Business

Table 67. AbbVie Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 68. AbbVie Latest Developments

Table 69. Gilead Sciences Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors

Table 70. Gilead Sciences Cystic Fibrosis Therapeutics Product Offered

Table 71. Gilead Sciences Main Business

Table 72. Gilead Sciences Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 73. Gilead Sciences Latest Developments

Table 74. Novartis Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors

Table 75. Novartis Cystic Fibrosis Therapeutics Product Offered

Table 76. Novartis Main Business

Table 77. Novartis Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 78. Novartis Latest Developments

Table 79. AstraZeneca Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors

Table 80. AstraZeneca Cystic Fibrosis Therapeutics Product Offered

Table 81. AstraZeneca Main Business

Table 82. AstraZeneca Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 83. AstraZeneca Latest Developments

Table 84. Bayer Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors

Table 85. Bayer Cystic Fibrosis Therapeutics Product Offered

Table 86. Bayer Main Business

Table 87. Bayer Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 88. Bayer Latest Developments

Table 89. Celtaxsys Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors

Table 90. Celtaxsys Cystic Fibrosis Therapeutics Product Offered

Table 91. Celtaxsys Main Business

Table 92. Celtaxsys Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 93. Celtaxsys Latest Developments

Table 94. Pharmaxis Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors

Table 95. Pharmaxis Cystic Fibrosis Therapeutics Product Offered

Table 96. Pharmaxis Main Business

Table 97. Pharmaxis Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 98. Pharmaxis Latest Developments

Table 99. ProQR Therapeutics Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors

Table 100. ProQR Therapeutics Cystic Fibrosis Therapeutics Product Offered

Table 101. ProQR Therapeutics Main Business

Table 102. ProQR Therapeutics Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 103. ProQR Therapeutics Latest Developments

Table 104. PTC Therapeutics Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors

Table 105. PTC Therapeutics Cystic Fibrosis Therapeutics Product Offered

Table 106. PTC Therapeutics Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 107. PTC Therapeutics Main Business

Table 108. PTC Therapeutics Latest Developments

Table 109. Alcresta Therapeutics Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors

Table 110. Alcresta Therapeutics Cystic Fibrosis Therapeutics Product Offered

Table 111. Alcresta Therapeutics Main Business

Table 112. Alcresta Therapeutics Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 113. Alcresta Therapeutics Latest Developments

Table 114. Insmed Incorporated Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors

Table 115. Insmed Incorporated Cystic Fibrosis Therapeutics Product Offered

Table 116. Insmed Incorporated Main Business

Table 117. Insmed Incorporated Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 118. Insmed Incorporated Latest Developments

Table 119. Savara Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors

Table 120. Savara Cystic Fibrosis Therapeutics Product Offered

Table 121. Savara Main Business

Table 122. Savara Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 123. Savara Latest Developments

Table 124. Cyclacel Pharmaceuticals Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors

Table 125. Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Product Offered

Table 126. Cyclacel Pharmaceuticals Main Business

Table 127. Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 128. Cyclacel Pharmaceuticals Latest Developments

Table 129. Vectura Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors

Table 130. Vectura Cystic Fibrosis Therapeutics Product Offered

Table 131. Vectura Main Business

Table 132. Vectura Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 133. Vectura Latest Developments

Table 134. Allergan Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors

Table 135. Allergan Cystic Fibrosis Therapeutics Product Offered

Table 136. Allergan Main Business

Table 137. Allergan Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 138. Allergan Latest Developments

List of Figures

Figure 1. Cystic Fibrosis Therapeutics Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Cystic Fibrosis Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Cystic Fibrosis Therapeutics Market Size Market Share by Type in 2021

Figure 7. Cystic Fibrosis Therapeutics in Hospitals

Figure 8. Global Cystic Fibrosis Therapeutics Market: Hospitals (2017-2022) & ($ Millions)

Figure 9. Cystic Fibrosis Therapeutics in Clinics

Figure 10. Global Cystic Fibrosis Therapeutics Market: Clinics (2017-2022) & ($ Millions)

Figure 11. Global Cystic Fibrosis Therapeutics Market Size Market Share by Application in 2021

Figure 12. Global Cystic Fibrosis Therapeutics Revenue Market Share by Player in 2021

Figure 13. Global Cystic Fibrosis Therapeutics Market Size Market Share by Regions (2017-2022)

Figure 14. Americas Cystic Fibrosis Therapeutics Market Size 2017-2022 ($ Millions)

Figure 15. APAC Cystic Fibrosis Therapeutics Market Size 2017-2022 ($ Millions)

Figure 16. Europe Cystic Fibrosis Therapeutics Market Size 2017-2022 ($ Millions)

Figure 17. Middle East & Africa Cystic Fibrosis Therapeutics Market Size 2017-2022 ($ Millions)

Figure 18. Americas Cystic Fibrosis Therapeutics Value Market Share by Country in 2021

Figure 19. Americas Cystic Fibrosis Therapeutics Consumption Market Share by Type in 2021

Figure 20. Americas Cystic Fibrosis Therapeutics Market Size Market Share by Application in 2021

Figure 21. United States Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 22. Canada Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 23. Mexico Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 24. Brazil Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 25. APAC Cystic Fibrosis Therapeutics Market Size Market Share by Region in 2021

Figure 26. APAC Cystic Fibrosis Therapeutics Market Size Market Share by Application in 2021

Figure 27. China Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 28. Japan Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 29. Korea Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 30. Southeast Asia Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 31. India Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 32. Australia Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 33. Europe Cystic Fibrosis Therapeutics Market Size Market Share by Country in 2021

Figure 34. Europe Cystic Fibrosis Therapeutics Market Size Market Share by Type in 2021

Figure 35. Europe Cystic Fibrosis Therapeutics Market Size Market Share by Application in 2021

Figure 36. Germany Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 37. France Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 38. UK Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 39. Italy Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 40. Russia Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Cystic Fibrosis Therapeutics Market Size Market Share by Region in 2021

Figure 42. Middle East & Africa Cystic Fibrosis Therapeutics Market Size Market Share by Type in 2021

Figure 43. Middle East & Africa Cystic Fibrosis Therapeutics Market Size Market Share by Application in 2021

Figure 44. Egypt Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 45. South Africa Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 46. Israel Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 47. Turkey Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 48. GCC Country Cystic Fibrosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 49. Americas Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 50. APAC Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 51. Europe Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 52. Middle East & Africa Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 53. United States Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 54. Canada Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 55. Mexico Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 56. Brazil Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 57. China Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 58. Japan Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 59. Korea Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 60. Southeast Asia Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 61. India Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 62. Australia Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 63. Germany Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 64. France Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 65. UK Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 66. Italy Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 67. Russia Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 68. Spain Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 69. Egypt Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 70. South Africa Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 71. Israel Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 72. Turkey Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 73. GCC Countries Cystic Fibrosis Therapeutics Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450